KatakamiN, UchinoJ, YokoyamaT, et al.Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04). Cancer, 2018; 124(3):606–616; doi: 10.1002/cncr.31128
2.
RoelandEJ, BohlkeK, BaracosVE, et al.Management of cancer cachexia: ASCO Guideline: ASCO Guideline. J Clin Oncol, 2020; 38(21):2438–2453; doi: 10.1200/JCO.20.00611
3.
DrewBJ, AckermanMJ, FunkM, et al.Prevention of torsade de pointes in hospital settings: A scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation, 2010; 121(8):1047–1060; doi: 10.1161/CIRCULATIONAHA.109.192704
4.
OkidonoY, OsadaJ, OtsuK, et al.Two cases of wide QRS complex tachycardia caused by anamorelin. J Cardiol Cases, 2022; 26(3):212–216; doi: 10.1016/j.jccase.2022.04.015
